References
- Block G, Dietrich M, Norkus EP, Morrow JD, Hudes M, Caan B, Packer L. (2002). Factors associated with oxidative stress in human populations. Am J Epidemiol 156:274–85.
- Block G, Jensen CD, Morrow JD, Holland N, Norkus EP, Milne GL, Hudes M, Dalvi TB, Crawford PB, Fung EB, Schumacher L, Harmatz P. (2008). The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 45:377–84.
- Craft NE, Brown ED, Smith JC, Jr. (1988). Effects of storage and handling conditions on concentrations of individual carotenoids, retinol, and tocopherol in plasma. Clin Chem 34:44–8.
- Doroshow JH, Synold TW, Somlo G, Akman SA, Gajewski E. (2001). Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin. Blood 97:2839–45.
- Halliwell B, Whiteman M. (2004). Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231–55.
- Halliwell B, Gutteridge JMC. (2007). Free Radicals in Biology and Medicine, 4th edition. Oxford: Oxford University Press.
- Hudson MB, Hosick PA, McCaulley GO, Schrieber L, Wrieden J, McAnulty SR, Triplett NT, McBride JM, Quindry JC. (2008). The effect of resistance exercise on humoral markers of oxidative stress. Med Sci Sports Exerc 40:542–48.
- Kadiiska MB, Gladen BC, Baird DD, Dikalova AE, Sohal RS, Hatch GE, Jones DP, Mason RP, Barrett JC. (2000). Biomarkers of oxidative stress study: are plasma antioxidants markers of CCl(4) poisoning? Free Radic Biol Med 28:838–45.
- Kadiiska MB, Gladen BC, Baird DD, Germolec D, Graham LB, Parker CE, Nyska A, Wachsman JT, Ames BN, Basu S. (2005). Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning? Free Radic Biol Med 38:698–710.
- Michailidis Y, Jamurtas AZ, Nikolaidis MG, Fatouros IG, Koutedakis Y, Papassotiriou I, Kouretas D. (2007). Sampling time is crucial for measurement of aerobic exercise-induced oxidative stress. Med Sci Sports Exerc 39:1107–13.
- Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. (2004). Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56:185–229.
- Mross K, Maessen P, van der Vijgh WJ, Gall H, Boven E, Pinedo HM. (1988). Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans. J Clin Oncol 6:517–26.
- Olinski R, Jaruga P, Foksinski M, Bialkowski K, Tujakowski J. (1997). Epirubicin-induced oxidative DNA damage and evidence for its repair in lymphocytes of cancer patients who are undergoing chemotherapy. Mol Pharmacol 52:882–5.
- Rajagopalan S, Politi PM, Sinha BK, Myers CE. (1988). Adriamycin-induced free radical formation in the perfused rat heart: implications for cardiotoxicity. Cancer Res 48:4766–9.
- Reznick AZ, Packer L. (1994). Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–63.
- Satomura Y, Kimura M, Itokawa Y. (1992). Simultaneous determination of retinol and tocopherols by HPLC. Clin Chem 38: 1189–90.
- Swain SM, Whaley FS, Ewer MS. (2003). Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. Cancer 97:2869–79.
- Weiss RB. (1992). The anthracyclines: will we ever find a better doxorubicin? Semin Oncol 19:670–86.
- White CC, Viernes H, Krejsa CM, Botta D, Kavanagh TJ. (2003). Fluorescence-based microtiter plate assay for glutamate-cysteine ligase activity. Anal Biochem 318:175–80.